Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05588388
What this trial is testing

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

Who this might be right for
Extensive-stage Small-cell Lung CancerLiver Metastases
Kamya Sankar 39
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Early research (Phase 1)Ended earlyNCT02819999
What this trial is testing

Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07547332
What this trial is testing

Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC

Who this might be right for
Small Cell Lung CancerExtensive Stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Pulmonary Hospital, Shanghai, China 84
Testing effectiveness (Phase 2)UnknownNCT04884009
What this trial is testing

A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 106
Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing

Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21
Testing effectiveness (Phase 2)Study completedNCT03325816
What this trial is testing

Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Cancer Extensive Stage
Georgetown University 9
Early research (Phase 1)Looking for participantsNCT07231445
What this trial is testing

Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 100
Early research (Phase 1)Study completedNCT00045604
What this trial is testing

Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Large-scale testing (Phase 3)Study completedNCT04449861
What this trial is testing

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 166
Not applicableStudy completedNCT05285033
What this trial is testing

RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

Who this might be right for
Small-cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 312
Testing effectiveness (Phase 2)Study completedNCT02735980
What this trial is testing

Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 133
Testing effectiveness (Phase 2)UnknownNCT05296603
What this trial is testing

Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hunan Province Tumor Hospital 83
Not applicableUnknownNCT04663438
What this trial is testing

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01987232
What this trial is testing

Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Amgen 32
Testing effectiveness (Phase 2)Study completedNCT00042978
What this trial is testing

Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT06030258
What this trial is testing

IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd. 120
Not applicableLooking for participantsNCT07244016
What this trial is testing

Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Henan Cancer Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT07778316
What this trial is testing

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

Who this might be right for
Small Cell Lung Cancer
Amgen 400
Next Page